Navigating Biomanufacturing's Future: Insights from Mike Tomasco and the Role of Katalyze AI
Navigating Biomanufacturing's Future: Insights from Mike Tomasco and the Role of Katalyze AI
Tomasco leverages over 20 years in biomanufacturing to drive AI-based innovation, integration, and efficiency, offering a roadmap for digital transformation in an evolving industry
By
Mike Tomasco
October 19, 2024
8
min read
In this article
8
min read
In the rapidly evolving biomanufacturing landscape, Mike Tomasco stands out as a seasoned leader, leveraging over two decades of expertise to drive innovation. His work underscores the critical need for integration and the adoption of advanced technologies, particularly artificial intelligence (AI), to enhance operational efficiency. By focusing on digital transformation, workforce development, and the strategic implementation of tools like Katalyze AI, Tomasco provides a roadmap for navigating the complexities of the biomanufacturing sector.
In the rapidly evolving biomanufacturing landscape, Mike Tomasco stands out as a seasoned leader, leveraging over two decades of expertise to drive innovation. His work underscores the critical need for integration and the adoption of advanced technologies, particularly artificial intelligence (AI), to enhance operational efficiency. By focusing on digital transformation, workforce development, and the strategic implementation of tools like Katalyze AI, Tomasco provides a roadmap for navigating the complexities of the biomanufacturing sector.
In the rapidly evolving biomanufacturing landscape, Mike Tomasco stands out as a seasoned leader, leveraging over two decades of expertise to drive innovation. His work underscores the critical need for integration and the adoption of advanced technologies, particularly artificial intelligence (AI), to enhance operational efficiency. By focusing on digital transformation, workforce development, and the strategic implementation of tools like Katalyze AI, Tomasco provides a roadmap for navigating the complexities of the biomanufacturing sector.
In the rapidly evolving biomanufacturing landscape, Mike Tomasco stands out as a seasoned leader, leveraging over two decades of expertise to drive innovation. His work underscores the critical need for integration and the adoption of advanced technologies, particularly artificial intelligence (AI), to enhance operational efficiency. By focusing on digital transformation, workforce development, and the strategic implementation of tools like Katalyze AI, Tomasco provides a roadmap for navigating the complexities of the biomanufacturing sector.
The ability to access data and act upon it is far more straightforward than it once was
The ability to access data and act upon it is far more straightforward than it once was
The ability to access data and act upon it is far more straightforward than it once was
The ability to access data and act upon it is far more straightforward than it once was
The Challenges of System Integration
Biomanufacturing is characterized by a multitude of complex and often fragmented technologies. For Tomasco, the challenge of integrating these disparate systems into a cohesive whole is paramount. "Integration between systems is one of the most difficult things to accomplish consistently,” he notes. Whether dealing with legacy equipment or state-of-the-art instruments, achieving seamless communication remains a persistent hurdle.
Despite advancements in technology, effective orchestration is vital. Tomasco emphasizes that orchestrators capable of managing data flow between systems are essential. "Data has to move in close to real-time, especially from equipment," he asserts. This capability is crucial for maintaining operational efficiency, as delays can adversely affect production timelines and regulatory compliance.
Biomanufacturing is characterized by a multitude of complex and often fragmented technologies. For Tomasco, the challenge of integrating these disparate systems into a cohesive whole is paramount. "Integration between systems is one of the most difficult things to accomplish consistently,” he notes. Whether dealing with legacy equipment or state-of-the-art instruments, achieving seamless communication remains a persistent hurdle.
Despite advancements in technology, effective orchestration is vital. Tomasco emphasizes that orchestrators capable of managing data flow between systems are essential. "Data has to move in close to real-time, especially from equipment," he asserts. This capability is crucial for maintaining operational efficiency, as delays can adversely affect production timelines and regulatory compliance.
Biomanufacturing is characterized by a multitude of complex and often fragmented technologies. For Tomasco, the challenge of integrating these disparate systems into a cohesive whole is paramount. "Integration between systems is one of the most difficult things to accomplish consistently,” he notes. Whether dealing with legacy equipment or state-of-the-art instruments, achieving seamless communication remains a persistent hurdle.
Despite advancements in technology, effective orchestration is vital. Tomasco emphasizes that orchestrators capable of managing data flow between systems are essential. "Data has to move in close to real-time, especially from equipment," he asserts. This capability is crucial for maintaining operational efficiency, as delays can adversely affect production timelines and regulatory compliance.
Biomanufacturing is characterized by a multitude of complex and often fragmented technologies. For Tomasco, the challenge of integrating these disparate systems into a cohesive whole is paramount. "Integration between systems is one of the most difficult things to accomplish consistently,” he notes. Whether dealing with legacy equipment or state-of-the-art instruments, achieving seamless communication remains a persistent hurdle.
Despite advancements in technology, effective orchestration is vital. Tomasco emphasizes that orchestrators capable of managing data flow between systems are essential. "Data has to move in close to real-time, especially from equipment," he asserts. This capability is crucial for maintaining operational efficiency, as delays can adversely affect production timelines and regulatory compliance.
Complexities in the Lab: The Need for Custom Solutions
While the challenges on the factory floor are significant, the lab environment presents even greater complexities. Laboratory instruments are often proprietary, with manufacturers exerting control over data flow, potentially limiting its application beyond their ecosystems. In these instances, the development of custom orchestration systems is frequently necessary. “You need that data to move to where it’s most valuable,” Tomasco emphasizes, highlighting the need for tailored solutions that bridge isolated platforms.
Platforms like Katalyze AI offer essential tools for streamlining the integration of diverse data sources, facilitating more effective data orchestration across various systems.
While the challenges on the factory floor are significant, the lab environment presents even greater complexities. Laboratory instruments are often proprietary, with manufacturers exerting control over data flow, potentially limiting its application beyond their ecosystems. In these instances, the development of custom orchestration systems is frequently necessary. “You need that data to move to where it’s most valuable,” Tomasco emphasizes, highlighting the need for tailored solutions that bridge isolated platforms.
Platforms like Katalyze AI offer essential tools for streamlining the integration of diverse data sources, facilitating more effective data orchestration across various systems.
While the challenges on the factory floor are significant, the lab environment presents even greater complexities. Laboratory instruments are often proprietary, with manufacturers exerting control over data flow, potentially limiting its application beyond their ecosystems. In these instances, the development of custom orchestration systems is frequently necessary. “You need that data to move to where it’s most valuable,” Tomasco emphasizes, highlighting the need for tailored solutions that bridge isolated platforms.
Platforms like Katalyze AI offer essential tools for streamlining the integration of diverse data sources, facilitating more effective data orchestration across various systems.
While the challenges on the factory floor are significant, the lab environment presents even greater complexities. Laboratory instruments are often proprietary, with manufacturers exerting control over data flow, potentially limiting its application beyond their ecosystems. In these instances, the development of custom orchestration systems is frequently necessary. “You need that data to move to where it’s most valuable,” Tomasco emphasizes, highlighting the need for tailored solutions that bridge isolated platforms.
Platforms like Katalyze AI offer essential tools for streamlining the integration of diverse data sources, facilitating more effective data orchestration across various systems.
AI: The Next Frontier in Biomanufacturing
When asked about the next transformative leap for biomanufacturing, Tomasco unequivocally identifies AI as a central player. “AI is going to be involved in some way,” he insists, acknowledging that its potential in research and development, as well as operational efficiency, remains largely untapped. Although AI has been employed in niche areas of the industry for years, recent years have accelerated its evolution. Tools such as Katalyze AI are becoming instrumental in reshaping data management and decision-making processes.
Tomasco regards generative AI (GenAI) as a potential catalyst for change but cautions that a robust operational foundation is essential. “You can’t just throw a Microsoft Copilot into the mix and expect miracles,” he argues. For AI to deliver meaningful insights, it must have access to substantial historical data. For example, integrating 20 years of quality data into an AI model can yield transformative outcomes, though the associated costs can be substantial.
Nonetheless, platforms like Katalyze AI are simplifying the integration of proprietary data into AI systems, thereby accelerating innovation while managing expenses.
When asked about the next transformative leap for biomanufacturing, Tomasco unequivocally identifies AI as a central player. “AI is going to be involved in some way,” he insists, acknowledging that its potential in research and development, as well as operational efficiency, remains largely untapped. Although AI has been employed in niche areas of the industry for years, recent years have accelerated its evolution. Tools such as Katalyze AI are becoming instrumental in reshaping data management and decision-making processes.
Tomasco regards generative AI (GenAI) as a potential catalyst for change but cautions that a robust operational foundation is essential. “You can’t just throw a Microsoft Copilot into the mix and expect miracles,” he argues. For AI to deliver meaningful insights, it must have access to substantial historical data. For example, integrating 20 years of quality data into an AI model can yield transformative outcomes, though the associated costs can be substantial.
Nonetheless, platforms like Katalyze AI are simplifying the integration of proprietary data into AI systems, thereby accelerating innovation while managing expenses.
When asked about the next transformative leap for biomanufacturing, Tomasco unequivocally identifies AI as a central player. “AI is going to be involved in some way,” he insists, acknowledging that its potential in research and development, as well as operational efficiency, remains largely untapped. Although AI has been employed in niche areas of the industry for years, recent years have accelerated its evolution. Tools such as Katalyze AI are becoming instrumental in reshaping data management and decision-making processes.
Tomasco regards generative AI (GenAI) as a potential catalyst for change but cautions that a robust operational foundation is essential. “You can’t just throw a Microsoft Copilot into the mix and expect miracles,” he argues. For AI to deliver meaningful insights, it must have access to substantial historical data. For example, integrating 20 years of quality data into an AI model can yield transformative outcomes, though the associated costs can be substantial.
Nonetheless, platforms like Katalyze AI are simplifying the integration of proprietary data into AI systems, thereby accelerating innovation while managing expenses.
When asked about the next transformative leap for biomanufacturing, Tomasco unequivocally identifies AI as a central player. “AI is going to be involved in some way,” he insists, acknowledging that its potential in research and development, as well as operational efficiency, remains largely untapped. Although AI has been employed in niche areas of the industry for years, recent years have accelerated its evolution. Tools such as Katalyze AI are becoming instrumental in reshaping data management and decision-making processes.
Tomasco regards generative AI (GenAI) as a potential catalyst for change but cautions that a robust operational foundation is essential. “You can’t just throw a Microsoft Copilot into the mix and expect miracles,” he argues. For AI to deliver meaningful insights, it must have access to substantial historical data. For example, integrating 20 years of quality data into an AI model can yield transformative outcomes, though the associated costs can be substantial.
Nonetheless, platforms like Katalyze AI are simplifying the integration of proprietary data into AI systems, thereby accelerating innovation while managing expenses.
Integrating Regulatory Considerations in Biomanufacturing
As the biomanufacturing landscape evolves, regulatory bodies, notably the FDA, are implementing significant updates that impact production processes. These changes emphasize enhanced product quality and safety, addressing the intricate challenges inherent in modern biomanufacturing. Companies must adapt by adopting robust quality management systems and ensuring compliance throughout the production lifecycle. This shift underscores the importance of aligning advanced technological implementations with regulatory expectations to maintain product integrity and safeguard patient safety. (You can read more about “AI in healthcare: Latest moves in Congress and what they portend for 2024” here.)
In light of Tomasco’s insights, the evolving regulatory environment serves as a critical context for the integration of cutting-edge technologies. Organizations leverage tools like Katalyze AI to enhance operational efficiency and they also navigate these regulatory demands.
As the biomanufacturing landscape evolves, regulatory bodies, notably the FDA, are implementing significant updates that impact production processes. These changes emphasize enhanced product quality and safety, addressing the intricate challenges inherent in modern biomanufacturing. Companies must adapt by adopting robust quality management systems and ensuring compliance throughout the production lifecycle. This shift underscores the importance of aligning advanced technological implementations with regulatory expectations to maintain product integrity and safeguard patient safety. (You can read more about “AI in healthcare: Latest moves in Congress and what they portend for 2024” here.)
In light of Tomasco’s insights, the evolving regulatory environment serves as a critical context for the integration of cutting-edge technologies. Organizations leverage tools like Katalyze AI to enhance operational efficiency and they also navigate these regulatory demands.
As the biomanufacturing landscape evolves, regulatory bodies, notably the FDA, are implementing significant updates that impact production processes. These changes emphasize enhanced product quality and safety, addressing the intricate challenges inherent in modern biomanufacturing. Companies must adapt by adopting robust quality management systems and ensuring compliance throughout the production lifecycle. This shift underscores the importance of aligning advanced technological implementations with regulatory expectations to maintain product integrity and safeguard patient safety. (You can read more about “AI in healthcare: Latest moves in Congress and what they portend for 2024” here.)
In light of Tomasco’s insights, the evolving regulatory environment serves as a critical context for the integration of cutting-edge technologies. Organizations leverage tools like Katalyze AI to enhance operational efficiency and they also navigate these regulatory demands.
As the biomanufacturing landscape evolves, regulatory bodies, notably the FDA, are implementing significant updates that impact production processes. These changes emphasize enhanced product quality and safety, addressing the intricate challenges inherent in modern biomanufacturing. Companies must adapt by adopting robust quality management systems and ensuring compliance throughout the production lifecycle. This shift underscores the importance of aligning advanced technological implementations with regulatory expectations to maintain product integrity and safeguard patient safety. (You can read more about “AI in healthcare: Latest moves in Congress and what they portend for 2024” here.)
In light of Tomasco’s insights, the evolving regulatory environment serves as a critical context for the integration of cutting-edge technologies. Organizations leverage tools like Katalyze AI to enhance operational efficiency and they also navigate these regulatory demands.
Capturing and Preserving Expert Knowledge
A pressing issue facing the biomanufacturing sector is the impending retirement of seasoned professionals. With younger entrants to the field often lacking the same depth of experience, the preservation of institutional knowledge becomes imperative. Tomasco urges biomanufacturers to act swiftly: “I think we have about five years to capture it,” he warns.
One innovative solution Tomasco has explored involves the use of virtual reality (VR) for training. During the COVID-19 pandemic, VR technology enabled the training of new employees without disrupting production. While early VR systems had limitations, the technology is advancing rapidly. "We were experimenting with haptic feedback gloves,” Tomasco recalls, envisioning a future where employees can engage physically with virtual objects during training, creating an immersive and realistic experience. This approach, coupled with AI platforms like Katalyze AI, holds promise for efficiently capturing and transferring expert knowledge.
A pressing issue facing the biomanufacturing sector is the impending retirement of seasoned professionals. With younger entrants to the field often lacking the same depth of experience, the preservation of institutional knowledge becomes imperative. Tomasco urges biomanufacturers to act swiftly: “I think we have about five years to capture it,” he warns.
One innovative solution Tomasco has explored involves the use of virtual reality (VR) for training. During the COVID-19 pandemic, VR technology enabled the training of new employees without disrupting production. While early VR systems had limitations, the technology is advancing rapidly. "We were experimenting with haptic feedback gloves,” Tomasco recalls, envisioning a future where employees can engage physically with virtual objects during training, creating an immersive and realistic experience. This approach, coupled with AI platforms like Katalyze AI, holds promise for efficiently capturing and transferring expert knowledge.
A pressing issue facing the biomanufacturing sector is the impending retirement of seasoned professionals. With younger entrants to the field often lacking the same depth of experience, the preservation of institutional knowledge becomes imperative. Tomasco urges biomanufacturers to act swiftly: “I think we have about five years to capture it,” he warns.
One innovative solution Tomasco has explored involves the use of virtual reality (VR) for training. During the COVID-19 pandemic, VR technology enabled the training of new employees without disrupting production. While early VR systems had limitations, the technology is advancing rapidly. "We were experimenting with haptic feedback gloves,” Tomasco recalls, envisioning a future where employees can engage physically with virtual objects during training, creating an immersive and realistic experience. This approach, coupled with AI platforms like Katalyze AI, holds promise for efficiently capturing and transferring expert knowledge.
A pressing issue facing the biomanufacturing sector is the impending retirement of seasoned professionals. With younger entrants to the field often lacking the same depth of experience, the preservation of institutional knowledge becomes imperative. Tomasco urges biomanufacturers to act swiftly: “I think we have about five years to capture it,” he warns.
One innovative solution Tomasco has explored involves the use of virtual reality (VR) for training. During the COVID-19 pandemic, VR technology enabled the training of new employees without disrupting production. While early VR systems had limitations, the technology is advancing rapidly. "We were experimenting with haptic feedback gloves,” Tomasco recalls, envisioning a future where employees can engage physically with virtual objects during training, creating an immersive and realistic experience. This approach, coupled with AI platforms like Katalyze AI, holds promise for efficiently capturing and transferring expert knowledge.
Advice for Future Biomanufacturing Professionals
For newcomers to the biomanufacturing industry, Tomasco’s advice is straightforward: actively manage your career trajectory. “Raise your hand,” he encourages, highlighting the importance of seeking out new responsibilities and opportunities. This proactive approach is key to building a reputation as a reliable problem-solver.
Moreover, he underscores the importance of making a tangible impact. "In our case, the customers are patients,” he notes. For professionals in biomanufacturing, the ultimate objective is to enhance patient outcomes, and understanding this broader purpose can be a powerful motivator for a fulfilling career.
For newcomers to the biomanufacturing industry, Tomasco’s advice is straightforward: actively manage your career trajectory. “Raise your hand,” he encourages, highlighting the importance of seeking out new responsibilities and opportunities. This proactive approach is key to building a reputation as a reliable problem-solver.
Moreover, he underscores the importance of making a tangible impact. "In our case, the customers are patients,” he notes. For professionals in biomanufacturing, the ultimate objective is to enhance patient outcomes, and understanding this broader purpose can be a powerful motivator for a fulfilling career.
For newcomers to the biomanufacturing industry, Tomasco’s advice is straightforward: actively manage your career trajectory. “Raise your hand,” he encourages, highlighting the importance of seeking out new responsibilities and opportunities. This proactive approach is key to building a reputation as a reliable problem-solver.
Moreover, he underscores the importance of making a tangible impact. "In our case, the customers are patients,” he notes. For professionals in biomanufacturing, the ultimate objective is to enhance patient outcomes, and understanding this broader purpose can be a powerful motivator for a fulfilling career.
For newcomers to the biomanufacturing industry, Tomasco’s advice is straightforward: actively manage your career trajectory. “Raise your hand,” he encourages, highlighting the importance of seeking out new responsibilities and opportunities. This proactive approach is key to building a reputation as a reliable problem-solver.
Moreover, he underscores the importance of making a tangible impact. "In our case, the customers are patients,” he notes. For professionals in biomanufacturing, the ultimate objective is to enhance patient outcomes, and understanding this broader purpose can be a powerful motivator for a fulfilling career.
Overcoming the Fear of Failure to Foster Innovation
Innovation is critical in biomanufacturing, yet fear often stifles progress. "There's a fear of making the wrong decision, fear of failure, fear of spending too much money," Tomasco admits. However, these fears can paralyze innovation. He advocates for a mindset focused on action, even at the risk of failure. "Do something. And if that doesn’t work, try something else,” he advises.
He emphasizes that inaction is also a decision—one that often leads to stagnation. By fostering a culture that embraces experimentation and iteration, biomanufacturing companies can unlock their full potential and drive groundbreaking innovations, particularly through the use of AI-powered tools like Katalyze AI.
Innovation is critical in biomanufacturing, yet fear often stifles progress. "There's a fear of making the wrong decision, fear of failure, fear of spending too much money," Tomasco admits. However, these fears can paralyze innovation. He advocates for a mindset focused on action, even at the risk of failure. "Do something. And if that doesn’t work, try something else,” he advises.
He emphasizes that inaction is also a decision—one that often leads to stagnation. By fostering a culture that embraces experimentation and iteration, biomanufacturing companies can unlock their full potential and drive groundbreaking innovations, particularly through the use of AI-powered tools like Katalyze AI.
Innovation is critical in biomanufacturing, yet fear often stifles progress. "There's a fear of making the wrong decision, fear of failure, fear of spending too much money," Tomasco admits. However, these fears can paralyze innovation. He advocates for a mindset focused on action, even at the risk of failure. "Do something. And if that doesn’t work, try something else,” he advises.
He emphasizes that inaction is also a decision—one that often leads to stagnation. By fostering a culture that embraces experimentation and iteration, biomanufacturing companies can unlock their full potential and drive groundbreaking innovations, particularly through the use of AI-powered tools like Katalyze AI.
Innovation is critical in biomanufacturing, yet fear often stifles progress. "There's a fear of making the wrong decision, fear of failure, fear of spending too much money," Tomasco admits. However, these fears can paralyze innovation. He advocates for a mindset focused on action, even at the risk of failure. "Do something. And if that doesn’t work, try something else,” he advises.
He emphasizes that inaction is also a decision—one that often leads to stagnation. By fostering a culture that embraces experimentation and iteration, biomanufacturing companies can unlock their full potential and drive groundbreaking innovations, particularly through the use of AI-powered tools like Katalyze AI.
Mike Tomasco’s insights illuminate the pivotal role of technology in shaping the future of biomanufacturing. Whether through system integration, AI utilization, or the preservation of expert knowledge, his approach underscores the necessity of forward-thinking leadership. Platforms like Katalyze AI are integral to this transformation, equipping organizations with the tools needed to harness AI’s capabilities and spur genuine innovation.
For those entering the field, Tomasco’s message is clear: be proactive, embrace innovation, and never shy away from the possibility of failure. In an industry where the stakes are high, this mindset, combined with the right technologies, can catalyze meaningful progress for companies and ultimately improve outcomes for the patients who depend on their products.
Mike Tomasco’s insights illuminate the pivotal role of technology in shaping the future of biomanufacturing. Whether through system integration, AI utilization, or the preservation of expert knowledge, his approach underscores the necessity of forward-thinking leadership. Platforms like Katalyze AI are integral to this transformation, equipping organizations with the tools needed to harness AI’s capabilities and spur genuine innovation.
For those entering the field, Tomasco’s message is clear: be proactive, embrace innovation, and never shy away from the possibility of failure. In an industry where the stakes are high, this mindset, combined with the right technologies, can catalyze meaningful progress for companies and ultimately improve outcomes for the patients who depend on their products.
Mike Tomasco’s insights illuminate the pivotal role of technology in shaping the future of biomanufacturing. Whether through system integration, AI utilization, or the preservation of expert knowledge, his approach underscores the necessity of forward-thinking leadership. Platforms like Katalyze AI are integral to this transformation, equipping organizations with the tools needed to harness AI’s capabilities and spur genuine innovation.
For those entering the field, Tomasco’s message is clear: be proactive, embrace innovation, and never shy away from the possibility of failure. In an industry where the stakes are high, this mindset, combined with the right technologies, can catalyze meaningful progress for companies and ultimately improve outcomes for the patients who depend on their products.
Mike Tomasco’s insights illuminate the pivotal role of technology in shaping the future of biomanufacturing. Whether through system integration, AI utilization, or the preservation of expert knowledge, his approach underscores the necessity of forward-thinking leadership. Platforms like Katalyze AI are integral to this transformation, equipping organizations with the tools needed to harness AI’s capabilities and spur genuine innovation.
For those entering the field, Tomasco’s message is clear: be proactive, embrace innovation, and never shy away from the possibility of failure. In an industry where the stakes are high, this mindset, combined with the right technologies, can catalyze meaningful progress for companies and ultimately improve outcomes for the patients who depend on their products.
Mike Tomasco
Mike Tomasco
Mike Tomasco
Mike Tomasco is a Vice President in Pfizer Digital with responsibility for leading Pfizer Global Supply’s (PGS) Digital Transformation. The goal of the program is to transform PGS through a business strategy driven focus on digitization applied end to end across Manufacturing and Supply Operations. Mr. Tomasco has experience across strategy, marketing, finance, manufacturing and information systems for multinational companies and has successfully led several major transformational initiatives.
Mike Tomasco is a Vice President in Pfizer Digital with responsibility for leading Pfizer Global Supply’s (PGS) Digital Transformation. The goal of the program is to transform PGS through a business strategy driven focus on digitization applied end to end across Manufacturing and Supply Operations. Mr. Tomasco has experience across strategy, marketing, finance, manufacturing and information systems for multinational companies and has successfully led several major transformational initiatives.
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
More Articles:
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
The AI Revolution in Genetic Medicine: Insights from Lee Bowman
Mediphage's COO, Lee Bowman, discusses AI's impact on genetic medicine, bio-manufacturing efficiency, industry challenges, and the importance of strategic collaboration.
Learn more
